BIOMAT Database Logo BIOMAT Database Logo

C1840-T mutation in the human skeletal muscle ryanodine receptor gene: frequency in northern German families susceptible to malignant hyperthermia and the relationship to in vitro contracture response. 1995

M Steinfath, and S Singh, and J Scholz, and K Becker, and C Lenzen, and F Wappler, and A Köchling, and N Roewer, and J Schulte am Esch
Abteilung für Anästhesiologie, Universität Hamburg, Universitäts-Krankenhaus Eppendorf.

In swine, a point mutation in the ryanodine receptor gene can account for all cases of malignant hyperthermia (MH). The frequency of a corresponding mutation in humans (C1840-T) and its relationship to the in vitro contracture profile is unknown. We screened 192 patients from 28 unrelated northern German families for the C1840-T mutation in the human ryanodine receptor gene and tested for MH susceptibility using the in vitro contracture test (IVCT) according to the European MH Protocol. In our patients 106 revealed MH susceptible (MHS), 56 MH nonsusceptible and 30 MH equivocal status following IVCT. In each family one or two individuals had developed clinical signs of MH or a MH crisis. All of these patients were classified MHS. The C1840-T mutation was found in 2 of 28 families (7.1%). All eight individuals of the two families characterized by this mutation revealed MHS status following IVCT. The thresholds for halothane- and caffeine-induced contractures as well as the contracture profiles following cumulative (0.4-10.0 mumol/l every 3 min) and bolus (10 mumol/l) administration of ryanodine were found to be similar in MHS patients with and without the C1840-T mutation. In conclusion, the C1840-T mutation in the human ryanodine receptor gene is a rare abnormality in MHS families. Similar contracture profiles in the presence and absence of this mutation might imply no major functional role with respect to the contracture response. At present, molecular genetic analysis cannot replace IVCT to discover MH susceptibility in humans.

UI MeSH Term Description Entries
D008297 Male Males
D008305 Malignant Hyperthermia Rapid and excessive rise of temperature accompanied by muscular rigidity following general anesthesia. Hyperpyrexia, Malignant,Hyperthermia, Malignant,Malignant Hyperpyrexia,Anesthesia Related Hyperthermia,Hyperthermia of Anesthesia,Anesthesia Hyperthermia,Hyperthermia, Anesthesia Related,Malignant Hyperpyrexias
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D009124 Muscle Proteins The protein constituents of muscle, the major ones being ACTINS and MYOSINS. More than a dozen accessory proteins exist including TROPONIN; TROPOMYOSIN; and DYSTROPHIN. Muscle Protein,Protein, Muscle,Proteins, Muscle
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D002110 Caffeine A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling. 1,3,7-Trimethylxanthine,Caffedrine,Coffeinum N,Coffeinum Purrum,Dexitac,Durvitan,No Doz,Percoffedrinol N,Percutaféine,Quick-Pep,Vivarin,Quick Pep,QuickPep
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children

Related Publications

M Steinfath, and S Singh, and J Scholz, and K Becker, and C Lenzen, and F Wappler, and A Köchling, and N Roewer, and J Schulte am Esch
Functional characterization of a distinct ryanodine receptor mutation in human malignant hyperthermia-susceptible muscle.
February 1997, The Journal of biological chemistry,
M Steinfath, and S Singh, and J Scholz, and K Becker, and C Lenzen, and F Wappler, and A Köchling, and N Roewer, and J Schulte am Esch
Increased sensitivity of the ryanodine receptor to halothane-induced oligomerization in malignant hyperthermia-susceptible human skeletal muscle.
January 2004, Journal of applied physiology (Bethesda, Md. : 1985),
M Steinfath, and S Singh, and J Scholz, and K Becker, and C Lenzen, and F Wappler, and A Köchling, and N Roewer, and J Schulte am Esch
Cosegregation of porcine malignant hyperthermia and a probable causal mutation in the skeletal muscle ryanodine receptor gene in backcross families.
November 1991, Genomics,
M Steinfath, and S Singh, and J Scholz, and K Becker, and C Lenzen, and F Wappler, and A Köchling, and N Roewer, and J Schulte am Esch
Changes in ryanodine-induced contractures by stimulus frequency in malignant hyperthermia susceptible and malignant hyperthermia nonsusceptible dog skeletal muscle.
September 1997, The Journal of pharmacology and experimental therapeutics,
M Steinfath, and S Singh, and J Scholz, and K Becker, and C Lenzen, and F Wappler, and A Köchling, and N Roewer, and J Schulte am Esch
The role of the skeletal muscle ryanodine receptor gene in malignant hyperthermia.
January 1992, Symposia of the Society for Experimental Biology,
M Steinfath, and S Singh, and J Scholz, and K Becker, and C Lenzen, and F Wappler, and A Köchling, and N Roewer, and J Schulte am Esch
Diltiazem and nifedipine reduce the in vitro contracture response to halothane in malignant hyperthermia-susceptible muscle.
July 1990, Canadian journal of anaesthesia = Journal canadien d'anesthesie,
M Steinfath, and S Singh, and J Scholz, and K Becker, and C Lenzen, and F Wappler, and A Köchling, and N Roewer, and J Schulte am Esch
Analysis of expression of the human ryanodine receptor gene in malignant hyperthermia skeletal muscle tissue.
February 1991, Biochemical Society transactions,
M Steinfath, and S Singh, and J Scholz, and K Becker, and C Lenzen, and F Wappler, and A Köchling, and N Roewer, and J Schulte am Esch
Screening of the ryanodine receptor gene in 105 malignant hyperthermia families: novel mutations and concordance with the in vitro contracture test.
October 1999, Human molecular genetics,
M Steinfath, and S Singh, and J Scholz, and K Becker, and C Lenzen, and F Wappler, and A Köchling, and N Roewer, and J Schulte am Esch
Ryanodine receptor gene point mutation and malignant hyperthermia susceptibility.
February 1995, Journal of neurology,
M Steinfath, and S Singh, and J Scholz, and K Becker, and C Lenzen, and F Wappler, and A Köchling, and N Roewer, and J Schulte am Esch
Novel skeletal muscle ryanodine receptor mutation in a large Brazilian family with malignant hyperthermia.
July 2002, Clinical genetics,
Copied contents to your clipboard!